Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (251-260 of 293) with videos related to

Pageof 30
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1991
[Clinical study of RU 23908 (nilutamide) in prostatic cancer]H Akaza, Y Aso, T Niijima, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1991
[Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial]H Akaza, S Kameyama, M Kanemura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1991
[A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors]I Fukui, S Komatsubara, H Akaza, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1991
[Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer]N Miyanaga, M Ohtani, R Noguchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1988
[Clinical efficacy of long-term treatment with LH-RH analogue, ICI 118630 (Zoladex), in prostatic cancer patients. The Zoladex Multicenter Study Group]M Usami, T Kotake, M Matsuda, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide)K Isurugi, T Niijima, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1988
[Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)]M Usami, T Kotake, M Matsuda, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1989
[Analyses of the effects of intravesical Bacillus Calmette-Guerin (Tokyo 172 strain) therapy of superficial bladder cancer]H Akaza, S Kameyama, K Koiso, et al.
Carcinogenesis|June 30, 2000
Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesisT Ota, M Asamoto, H Toriyama-Baba, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Pageof 30

Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1991
[Clinical study of RU 23908 (nilutamide) in prostatic cancer]H Akaza, Y Aso, T Niijima, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1991
[Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial]H Akaza, S Kameyama, M Kanemura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 1, 1991
[A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors]I Fukui, S Komatsubara, H Akaza, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1991
[Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer]N Miyanaga, M Ohtani, R Noguchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 1, 1988
[Clinical efficacy of long-term treatment with LH-RH analogue, ICI 118630 (Zoladex), in prostatic cancer patients. The Zoladex Multicenter Study Group]M Usami, T Kotake, M Matsuda, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide)K Isurugi, T Niijima, H Akaza, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1988
[Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)]M Usami, T Kotake, M Matsuda, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1989
[Analyses of the effects of intravesical Bacillus Calmette-Guerin (Tokyo 172 strain) therapy of superficial bladder cancer]H Akaza, S Kameyama, K Koiso, et al.
Carcinogenesis|June 30, 2000
Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesisT Ota, M Asamoto, H Toriyama-Baba, et al.
Cancer Research|September 15, 1996
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumorsT Shimazui, J A Schalken, L A Giroldi, et al.
Pageof 30